A 44-year-old male patient (body mass index \[BMI\], 21.22 kg/m^2^) was admitted to our hospital with intermittent severe epigastric pain radiating to the left shoulder for 2 months. He had a history of acute pancreatitis 4 months prior when his BMI was 32.65 kg/m^2^. Magnetic resonance cholangiopancreatography revealed two cystic lesions, one at the pancreatic tail measuring approximately 7.5 cm × 7.0 cm × 3.5 cm and the other within the splenic capsule measuring approximately 13.0 cm × 10.0 cm × 5.5 cm \[[Figure 1](#F1){ref-type="fig"}\]. The patient was diagnosed with pancreatic pseudocyst (PP) and splenic subscapular collection (SSC) complicated by moderately severe acute pancreatitis.

![Images of the two cystic lesions. (a) Magnetic resonance cholangiopancreatography shows a splenic fluid space attached to the pancreatic tail and pancreatic pseudocyst at the pancreatic tail. (b) Computed tomography-guided percutaneous drainage of the splenic subcapsular collection](EUS-7-61-g001){#F1}

After admission, computed tomography-guided percutaneous drainage of the SSC was performed with a 10-Fr pigtail tube. The amylase level of the brown fluid was 5641 U/L. The tube was removed 8 days later when the drainage volume decreased to 10 mL/day. An EUS-guided cystogastrostomy was performed 4 days after percutaneous puncture in the upper gastric body, adjacent to the cardia. The lumen of the lumen-apposing metal stent (LAMS) showed an opening toward the esophagus and complete coverage of the gastric cardia with anchor flange, which is supposed to be in the stomach \[[Figure 2](#F2){ref-type="fig"}\]. A nasogastric feeding tube was deployed instantaneously, by passing the stent, under endoscopic control \[[Figure 3](#F3){ref-type="fig"}\]. The amylase level of the cyst fluid was 66,096 U/L.

![Drainage of the pancreatic pseudocyst. (a) EUS-guided puncture. (b) Fluoroscopic image immediately after deployment of lumen-apposing metal stent within the pseudocyst. (c) Endoscopic view of lumen-apposing metal stent immediately after deployment as viewed from the lower esophagus](EUS-7-61-g002){#F2}

![Imaging 3 days after drainage. Nasogastric feeding tube ensures adequate intake (arrowhead). (a) Computed tomography showing lumen-apposing metal stent and percutaneous drainage tube with resolution of lesions. (b) Fluoroscopy showing lumen-apposing metal stent and iodixanol flowing into the pseudocyst](EUS-7-61-g003){#F3}

By day 3, the patient reported complete resolution of pain and requested oral intake. Upper gastrointestinal contrast fluoroscopy revealed iodinated contrast media flowing into the PP cavity along the lumen of the LAMS \[[Figure 3](#F3){ref-type="fig"}\]. The nasogastric tube was then used for enteral nutrition. The patient experienced rapid improvement and complete resolution of the PP upon imaging at the 3-week follow-up. The LAMS was retrieved endoscopically. An abdominal radiography was performed 60 h after removal to ensure the absence of gastric fistula \[[Figure 4](#F4){ref-type="fig"}\]. Oral eating was then permitted and the patient remains asymptomatic 3 months later.

![Stent removal. (a) Mucosal overgrowth at the gastric end of the stent after 27 days. (b) Safe removal using a snare. (c) Endoscopic view of fistula after removal (arrowhead). (d) Fluoroscopy confirmed healing of the gastric fistula](EUS-7-61-g004){#F4}

Splenic complications can be expected in acute pancreatitis, especially with an inflammatory process originating from the tail of the pancreas into the hilum of the spleen, which likely occurred in our case. Percutaneous drainage is the recommended treatment option for these complications.\[[@ref1][@ref2]\] EUS-guided cystogastrostomy of a PP is a well-established procedure.\[[@ref3][@ref4][@ref5]\] Recently, the introduction of the novel LAMS has made transmural intervention more effective.\[[@ref6][@ref7][@ref8]\] In our case, the cystogastrostomy process was imperfect because the cardia was blocked because of the upper puncture position. Fortunately, the large stent diameter allowed rapid adequate drainage and the nutrition tube was just placed for 27 days. We recommend choosing the lower part of the stomach as the puncture point, or designing a shorter LAMS, to avoid this complication.

Acute pancreatitis complicated simultaneously by PP and SSC is not uncommon. We treated both conditions during the initial hospitalization. Cardia occlusion by LAMS during the EUS-guided procedure retarded oral administration; we are the first to report this complication associated with LAMS.\[[@ref9][@ref10]\] This was successfully solved by placement of a nasogastric feeding tube.
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